Home / Stocks / TRABI
Back to all stocks
BSE · TRABI

Transgene Biotek Ltd. (TRABI) Share Price

Sector: Healthcare · ISIN: INE773D01018

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#5,011
of 5,047 stocks
▼ 121W▼ 251M
Peak #4,937 · 02 Oct 2026

Operating in Healthcare, Transgene Biotek Ltd. trades at an undemanding earnings multiple, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 24%. Ownership as of Jun 2026.

Market Cap
1.85 Cr
P/E Ratio
11.09
P/B Ratio
0.22
ROE
-19.73%
ROCE
-0.45%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q4 2025-26Q3 2025-26Q2 2025-26
Revenue6.00 L5.45 L5.45 L5.28 L
Net Profit-38.90 L-45.70 L-37.37 L-38.84 L
EPS0.050.060.050.05
Operating Profit-9.95 L-18.02 L-10.02 L-12.41 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
23.64%
Public
76.36%

PUBLIC BREAKDOWN

Individuals
71.88%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs